Contract A207_PO-0462067-V2

The University of Virginia awarded a contract to Novogene Corporation Inc. on July 27, 2026, for genomic sequencing services. The contract, identified as A207_PO-0462067-V2, is valued at $2,704.00 and encompasses plant and animal ChIP-seq (chromatin immunoprecipitation followed by sequencing) analysis. The scope includes deoxyribonucleic acid (DNA) sample quality control and sequencing on a NovaSeq X Plus Series instrument configured for paired-end 150-base reads, with a total data output of 12 gigabytes per sample across 16 samples. The deliverable will be directed to Min Xiang.

The contract represents a single-line-item procurement executed in Virginia. While the specific performance location is not explicitly detailed in the award documentation, the engagement reflects the University of Virginia's requirement for specialized molecular biology services to support research initiatives. No information regarding contract period of performance, renewal options, or additional contract value metrics beyond the cumulative award amount of $2,704.00 is provided in the available contract documents.